Benralizumab reduces daily oral prednisone dose for severe asthma from 10 mg to 5 mg

Benralizumab reduces daily oral prednisone dose for severe asthma from 10 mg to 5 mg is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central